| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |







From the Department of Molecular Cytogenetics,*Medical Research Institute, Tokyo Medical and Dental University, Tokyo; the Department of Thoracic Surgery,
Chiba University Graduate School of Medicine, Chiba; the Divisions of Molecular Oncology and Immunology,
Aichi Cancer Center Research Institute, Nagoya; the Pathology Division,
National Cancer Center Research Institute, Tokyo; and the Department of Molecular Pathology,¶Tohoku University Graduate School of Medicine, Sendai, Japan
We investigated DNA copy-number aberrations in 22 cell lines derived from small cell lung cancers (SCLCs) using comparative genomic hybridization. A minimal common region at 5p13, within the 5p11-p13 amplicon that was most frequently involved, harbored the CDH6, PC4, and SKP2 genes. These three genes showed amplification and consequent overexpression in the SCLC cell lines. SKP2 positively regulates progression of cell cycle by targeting several regulators, such as the cell-cycle inhibitor p27KIP1, for ubiquitin-mediated degradation. SKP2 was amplified in 7 (44%) of 16 primary SCLC tumors, and consequently overexpressed in 10 (83%) of the 12 of those tumors we examined. Expression levels of SKP2 protein were cell cycle-dependent in SCLC cells as well as in normal cells, and were correlated with the DNA copy-number of the gene. There was an inverse correlation between the expression of SKP2 and p27KIP1 proteins. Down-regulation of SKP2 using an anti-sense oligonucleotide remarkably suppressed the growth of SCLC cells. Our results indicate that SKP2 is likely to be a target of the 5p13 amplification and to play an important role in the growth of SCLC cells.
Related articles in Am J Pathol:
This article has been cited by other articles:
![]() |
G. Chiappetta, C. De Marco, A. Quintiero, D. Califano, S. Gherardi, D. Malanga, M. Scrima, C. Montero-Conde, L. Cito, M. Monaco, et al. Overexpression of the S-phase kinase-associated protein 2 in thyroid cancer Endocr. Relat. Cancer, June 1, 2007; 14(2): 405 - 420. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-C. Chang, F.-R. Chang, Y.-C. Wang, M.-R. Pan, W.-C. Hung, and Y.-C. Wu A bioactive withanolide Tubocapsanolide A inhibits proliferation of human lung cancer cells via repressing Skp2 expression Mol. Cancer Ther., May 1, 2007; 6(5): 1572 - 1578. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Sonoda, H. Inoue, K. Ogawa, T. Utsunomiya, T.-a. Masuda, and M. Mori Significance of Skp2 Expression in Primary Breast Cancer Clin. Cancer Res., February 15, 2006; 12(4): 1215 - 1220. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-Y. Huang, H.-Y. Kang, C.-F. Li, H.-L. Eng, S.-C. Chou, C.-N. Lin, and C.-Y. Hsiung Skp2 Overexpression Is Highly Representative of Intrinsic Biological Aggressiveness and Independently Associated with Poor Prognosis in Primary Localized Myxofibrosarcomas Clin. Cancer Res., January 15, 2006; 12(2): 487 - 498. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Kudo, S. Kitajima, I. Ogawa, M. Kitagawa, M. Miyauchi, and T. Takata Small interfering RNA targeting of S phase kinase-interacting protein 2 inhibits cell growth of oral cancer cells by inhibiting p27 degradation Mol. Cancer Ther., March 1, 2005; 4(3): 471 - 476. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kitajima, Y. Kudo, I. Ogawa, T. Bashir, M. Kitagawa, M. Miyauchi, M. Pagano, and T. Takata Role of Cks1 Overexpression in Oral Squamous Cell Carcinomas: Cooperation with Skp2 in Promoting p27 Degradation Am. J. Pathol., December 1, 2004; 165(6): 2147 - 2155. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Osoegawa, I. Yoshino, S. Tanaka, K. Sugio, T. Kameyama, M. Yamaguchi, and Y. Maehara Regulation of p27 by S-Phase Kinase-Associated Protein 2 Is Associated With Aggressiveness in Non-Small-Cell Lung Cancer J. Clin. Oncol., October 15, 2004; 22(20): 4165 - 4173. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Yokoi, K. Yasui, M. Mori, T. Iizasa, T. Fujisawa, and J. Inazawa Amplification and Overexpression of SKP2 Are Associated with Metastasis of Non-Small-Cell Lung Cancers to Lymph Nodes Am. J. Pathol., July 1, 2004; 165(1): 175 - 180. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Q. Zhu, F. H. Blackhall, M. Pintilie, P. Iyengar, N. Liu, J. Ho, T. Chomiak, D. Lau, T. Winton, F. A. Shepherd, et al. Skp2 Gene Copy Number Aberrations Are Common in Non-Small Cell Lung Carcinoma, and Its Overexpression in Tumors with ras Mutation Is a Poor Prognostic Marker Clin. Cancer Res., March 15, 2004; 10(6): 1984 - 1991. [Abstract] [Full Text] [PDF] |
||||
![]() |
T.-a. Masuda, H. Inoue, K. Nishida, H. Sonoda, Y. Yoshikawa, Y. Kakeji, T. Utsunomiya, and M. Mori Cyclin-Dependent Kinase 1 Gene Expression Is Associated with Poor Prognosis in Gastric Carcinoma Clin. Cancer Res., November 15, 2003; 9(15): 5693 - 5698. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Yokoi, K. Yasui, T. Iizasa, I. Imoto, T. Fujisawa, and J. Inazawa TERC Identified as a Probable Target within the 3q26 Amplicon That Is Detected Frequently in Non-Small Cell Lung Cancers Clin. Cancer Res., October 15, 2003; 9(13): 4705 - 4713. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |